← Leaderboards
Steven C Plaxe
University Of California San Diego
$0
Attributed
$0
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 1
By mechanism
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Stephen A Spector$452,436
- Thomas J. Kipps$21,947,102
- Jeffrey T Chang$4,144,512
- John C Gillin$665,812
- Susan Little$46,798,571
Others in their field
Top investigators on “Blood Chemistry”
- Thomas William Geisbert · Boston University Medical Campus$36,787,680
- Xinhua Li · Nano Terra, Inc.$24,053,962
- Reshan Fernando · Research Triangle Institute$21,790,231
- Steven H Liang · Emory University$21,786,353
- Boris Tabakoff · University Of Colorado Denver$21,692,834
- Michael Welch · Washington University$18,835,712
Research focus
Blood ChemistryCis Platinum CompoundClinical ResearchCombination Cancer TherapyCytotoxicityDrug Administration Rate /DurationDrug Adverse EffectDrug Screening /EvaluationEpitheliumHuman MortalityHuman SubjectHuman Therapy EvaluationInjection /InfusionNeoplasm /Cancer ChemotherapyNeoplasm /Cancer Classification /StagingNeoplastic ProcessOvary NeoplasmsPaclitaxel
Grant awards (9)
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2002 · RR
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2002 · RR
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2002 · RR
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2002 · RR
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2001 · RR
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2001 · RR
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2000 · RR
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2000 · RR
GOG 162 CISPLATIN &PACLITAXEL IN OVARIAN CANCER$0
M01 · FY2000 · RR